More recently, resibufogenin, a member of the bufadienolide family, is proven to suppress the growth and metastasis of CRC by inducing necroptosis in vivo through the upregulation of RIPK3 and the phosphorylation of MLKL at Ser358 [156]. The gene discussed is MLKL; the disease is colorectal carcinoma.